↓ Skip to main content

Remote Sensing Between Liver and Intestine: Importance of Microbial Metabolites

Overview of attention for article published in Current Pharmacology Reports, March 2017
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
6 X users
facebook
1 Facebook page

Citations

dimensions_citation
49 Dimensions

Readers on

mendeley
86 Mendeley
Title
Remote Sensing Between Liver and Intestine: Importance of Microbial Metabolites
Published in
Current Pharmacology Reports, March 2017
DOI 10.1007/s40495-017-0087-0
Pubmed ID
Authors

Zidong Donna Fu, Julia Yue Cui

Abstract

Recent technological advancements including metagenomics sequencing and metabolomics have allowed the discovery of critical functions of gut microbiota in obesity, malnutrition, neurological disorders, asthma, and xenobiotic metabolism. Classification of the human gut microbiome into distinct "enterotypes" has been proposed to serve as a new paradigm for understanding the interplay between microbial variation and human disease phenotypes, as many organs are affected by gut microbiota modifications during the pathogenesis of diseases. Gut microbiota remotely interacts with liver and other metabolic organs of the host through various microbial metabolites that are absorbed into the systemic circulation. The present review summarizes recent literature regarding the importance of gut microbiota in modulating the physiological and pathological responses of various host organs, and describes the functions of the known microbial metabolites that are involved in this remote sensing process, with a primary focus on the gut microbiota-liver axis. Under physiological conditions, gut microbiota modulates the hepatic transcriptome, proteome, and metabolome, most notably down-regulating cytochrome P450 3a mediated xenobiotic metabolism. Gut microbiome also modulates the rhythmicity in liver gene expression, likely through microbial metabolites, such as butyrate and propionate that serve as epigenetic modifiers. Additionally, the production of host hormones such as primary bile acids and glucagon like peptide 1 is altered by gut microbiota to modify intermediary metabolism of the host. Dysregulation of gut microbiota is implicated in various liver diseases such as alcoholic liver disease, non-alcoholic steatohepatitis, liver cirrhosis, cholangitis, and liver cancer. Gut microbiota modifiers such as probiotics and prebiotics are increasingly recognized as novel therapeutic modalities for liver and other types of human diseases.

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 86 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 86 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 17%
Student > Master 9 10%
Student > Ph. D. Student 8 9%
Student > Bachelor 8 9%
Other 6 7%
Other 11 13%
Unknown 29 34%
Readers by discipline Count As %
Medicine and Dentistry 15 17%
Agricultural and Biological Sciences 9 10%
Biochemistry, Genetics and Molecular Biology 6 7%
Immunology and Microbiology 6 7%
Nursing and Health Professions 3 3%
Other 13 15%
Unknown 34 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 November 2017.
All research outputs
#13,888,754
of 23,552,911 outputs
Outputs from Current Pharmacology Reports
#1
of 1 outputs
Outputs of similar age
#163,599
of 311,795 outputs
Outputs of similar age from Current Pharmacology Reports
#1
of 1 outputs
Altmetric has tracked 23,552,911 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1 research outputs from this source. They receive a mean Attention Score of 0.0. This one scored the same or higher as 0 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 311,795 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them